Permanent Mechanical Circulatory Support

  • Tofy Mussivand
  • Paul J. Hendry
  • Roy G. Masters
  • Wilbert J. Keon
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 225)


Mechanical circulatory support devices have typically been used for temporary support and as a bridge to transplantation. The experience gained with the existing devices, specifically the extended durations of successful support, has led to raised expectations for the more chronic and permanent use of mechanical circulatory devices. 1-3 While some currently available systems are now being utilized for extended durations outside of the hospital setting, systems are being developed utilizing advanced technologies which will allow for longer term out of hospital, circulatory support.4-5


Circulatory Support Ventricular Assist Device Mechanical Circulatory Support Heart Lung Transplant Native Heart 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Frazier OH, Long-term ventricular support with the Heartmate in patients undergoing bridge-to-transplant operations. Cardiac Surgery: State of the Art Reviews 1993;7:353–62.Google Scholar
  2. 2.
    McCarthy PM, Young JB, Smedira NG, Hobbs RE, Vargo RL, Starling RC. Permanent mechanical circulatory support with an implantable left ventricular assist device. Ann Thorac Surg 1997;63:1458–61PubMedCrossRefGoogle Scholar
  3. 3.
    Oz MC, Argenziano M, Catanese KA, et al. Bridge experience with long-term implantable left ventricular assist devices: Are they an alternative to transplantation? Circulation 1997;95:1844–52.PubMedGoogle Scholar
  4. 4.
    Catanese KA, Goldstein DJ, Williams DL, et al. Outpatient left ventricular assist device support: A destination rather than a bridge. Ann Thorac Surg 1996;62:646–53.PubMedCrossRefGoogle Scholar
  5. 5.
    Myers TJ, Catanese KA, Vargo RL, Dresslers DK. Extended cardiac support with a portable left ventricular assist system in the home. ASAIO J 1996;42:M576–9.PubMedGoogle Scholar
  6. 6.
    Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301–6.PubMedGoogle Scholar
  7. 8.
    Kannel WB. Epidemiology aspects of heart failure. Cardiol Clin 1989;7:1–9.PubMedGoogle Scholar
  8. 9.
    Massie BM, Packer M. Congestive heart failure: Current controversies and future prospects. Am J Cardiol 1990;66:429–30.CrossRefGoogle Scholar
  9. 11.
    Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993:22:6A–13A.PubMedCrossRefGoogle Scholar
  10. 12.
    Goldstein DL, Oz MC, Rose EA. Implantable ventricular assist devices. N Engl J Med 1998;339:1522–33.PubMedCrossRefGoogle Scholar
  11. 13.
    Cooley DA. A brief history of heart transplants and mechanical assist devices. In: Frazier OH. Support and replacement of the failing heart. Lippincott Raven, Philadelphia, USA, 1996:5–15.Google Scholar
  12. 14.
    Arabia FA, Copeland JG, Smith RG, et al. International experience with the CardioWest total artificial heart as a bridge to heart transplantation. Eur J Cardiothorac Surg 1997;11:S5–10.CrossRefGoogle Scholar
  13. 15.
    Cowen &0026; Company: Cardiovascular Device Update, December 1997Google Scholar
  14. 16.
    Hunt SA, Frazier OH, Myers TJ. Mechanical circulatory support and cardiac transplantation. Circulation 1998;97:2079–90.PubMedGoogle Scholar
  15. 17.
    Rose EA, Goldstein DJ. Wearable long-term mechanical support for patients with end-stage heart disease: A tenable goal. Ann Thorac Surg 1996;61:399–402.PubMedCrossRefGoogle Scholar
  16. 18.
    Loisance DY, Deleuze PH, Mazzucotelli JP, Le Besnerais P, Dubois-Rande JL. Clinical implantation of the wearable Baxter Novacor ventricular assist system. Ann Thorac Surg 1994,58:551–4.PubMedCrossRefGoogle Scholar
  17. 19.
    Frazier OH. Evolution of battery-powered, vented left ventricular assist devices. Ann Thorac Surg 1996;61393–5.Google Scholar
  18. 20.
    Viganó, Scuri S, Cobelli F, et al. Staged discharge out of hospital of the Novacor left ventricular assist system (LVAS) recipients. Eur J Cardiothorac Surg 1997;11:S45–50.Google Scholar
  19. 21.
    Fey O, El-Banayosy A, Arosuglu L, Posival H, Körfer R. Out-of-hospital experience in patients with implantable mechanical circulatory support: present and future trends. Eur J Cardiothorac Surg 1997;11:S51–3.CrossRefGoogle Scholar
  20. 22.
    Frazier OH, Rose EA, Macmanus Q, et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg 1992;53:1080–90.PubMedCrossRefGoogle Scholar
  21. 23.
    Levin HR, Chen JM, Oz MC, et al. Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg 1994;58:1515–20.PubMedCrossRefGoogle Scholar
  22. 24.
    Kormos RL, Murali S, Dew MA, et al. Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival. Ann Thorac Surg 1994;57:51–8.PubMedCrossRefGoogle Scholar
  23. 25.
    Miller PJ, Billich TJ, LaForge DH, et al. Initial clinical experience with a wearable controller for the Novacor left ventricular assist system. ASAIO J 1994;40:M465–70.PubMedCrossRefGoogle Scholar
  24. 26.
    Mehta SM, Aufiero TX, Pae WE Jr., Miller CA, Pierce WS. Combined registry for the clinical use of mechanical ventricular assist pumps and the total artificial heart in conjunction with heart transplantation: sixth official report-1994. J Heart Lung Transplant 1995;14:585–93.PubMedGoogle Scholar
  25. 27.
    Holman WL, Murrah CP, Ferguson ER, Bourge RC, McGiffin DC, Kirklin JK. Infections during extended circulatory support: University of Alabama at Birmingham experience 1989 to 1994. Ann Thorac Surg 1996;61:366–71.PubMedCrossRefGoogle Scholar
  26. 28.
    El-Amir NG, Gardocki M, Levin HR, et al. Gastrointestinal consequences of left ventricular assist device placement. ASAIO J 1996;42:150–3.PubMedCrossRefGoogle Scholar
  27. 29.
    McCarthy PM, Wang N, Vargo RL. Preperitoneal insertion of the HeartMate 1000 IP implantable left ventricular assist device. Ann Thorac Surg 1994; 57:634–8.PubMedCrossRefGoogle Scholar
  28. 30.
    Stevenson LW. Patient selection for mechanical bridging to transplantation. Ann Thorac Surg 1996;61:380–7.PubMedCrossRefGoogle Scholar
  29. 31.
    Pennington DG. Extended support with permanent systems: Percutaneous versus totally implantable. Ann Thorac Surg 1996;61:403–6.PubMedCrossRefGoogle Scholar
  30. 32.
    McCarthy PM, Schmitt SK, Vargo RL, Gordon S, Keys TF, Hobbs RE. Implantable LVAD infections: Implications for permanent use of the device. Ann Thorac Surg 1996;61:359–65.PubMedCrossRefGoogle Scholar
  31. 33.
    Watson JT. Innovative ventricular assist systems. ASA1O J 1994;40:M902.Google Scholar
  32. 34.
    Massad MG, McCarthy PM. Will permanent LVADs be better than heart transplantation? Eur J Cardiothorac Surg 1997;11:S11–7.CrossRefGoogle Scholar
  33. 35.
    McManus RP, O’Hair DP, Beitzinger JM, et al. Patients who die awaiting heart transplantation. J Heart Lung Transplant 1993;12:159–72.PubMedGoogle Scholar
  34. 36.
    Cloy MJ, Myers TJ, Stutts LA, Macris MP, Frazier OH. Hospital charges for conventional therapy versus left ventricular assist system therapy in heart transplant patients. ASAIO J 1995; 41:M535–9.PubMedGoogle Scholar
  35. 37.
    Frazier OH. First use of an untethered, vented electric left ventricular assist device for long-term support. Circulation 1994;89:2908–14.PubMedGoogle Scholar
  36. 38.
    Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995;91:2717–20.PubMedGoogle Scholar
  37. 39.
    Dipla K, Mattielo JA, Jeevanandam V, Houser SR, Margulies KB. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 1998;97:2316–22.PubMedGoogle Scholar
  38. 40.
    Meuller J, Semrau S, Spiegelsberger S, et al. Factors influencing the possibility of weaning from mechanical cardiac support systems in patients with end-stage idiopathic dilated cardiomyopathy. ASAIO Abstracts 1997:26:43.CrossRefGoogle Scholar
  39. 41.
    McCarthy PM, Nakatani S, Vargo R, et al. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg 1995;59:609–13.PubMedCrossRefGoogle Scholar
  40. 42.
    Farrar DJ, Hill JD. Thoratec Ventricular Assist Device Principal Investigators. Recovery of major organ function in patients awaiting heart transplantation with Thoratec ventricular assist devices. J Heart Lung Transplant 1994;13:1125–32.PubMedGoogle Scholar
  41. 44.
    Guy TS. Evolution and the current status of the total artificial heart: The search continues. ASAIO J 1998;44:28–33.PubMedCrossRefGoogle Scholar
  42. 45.
    Orime Y, Takatani S, Ohara Y, et al. The Baylor-ABI electromechanical total artificial heart. Accelerated endurance testing. ASAIO J 1993;39:M172–6.PubMedCrossRefGoogle Scholar
  43. 46.
    Gao H, Smith LM, Krymkowski MG, Kohl RJ, Schmidt DH, Christensen CW. In vitro assessment of the Milwaukee Heart and right to left balance. ASAIO J 1992;38:M722–5.PubMedCrossRefGoogle Scholar
  44. 47.
    Cowen &0026; Company: Industry strategies: Congestive heart failure: Blockbuster potential for emerging therapies, September 1994.Google Scholar
  45. 48.
    Mussivand TV, Masters RG, Hendry PJ, Keon WJ. Totally implantable intrathoracic ventricular assist device. Ann Thorac Surg 1996;61:444–7.PubMedCrossRefGoogle Scholar
  46. 49.
    Mussivand T, Hendry PJ, Masters RG, Keon WJ. Evaluation of a totally implantable intrathoracic ventricular assist device. Cor Europaeum 1997;6:110–4.Google Scholar
  47. 50.
    Mussivand T, Hendry PJ, Masters RG, Keon WJ. Multi-purpose mechanical circulatory device. Int J Artif Organs 1997;20:217–21.PubMedGoogle Scholar
  48. 51.
    Nojiri C, Kijima T, Horiuchi K. et al. Recent progress in the development of Terumo implantable LVAS (T-ILVAS). ASAIO Abstracts 1998;44:39.Google Scholar
  49. 52.
    Macha M, Litwak P, Yamazaki K, et al. Survival for up to six months in calves supported with an implantable axial flow ventricular assist device. ASAIO J 1997;43:311–5PubMedCrossRefGoogle Scholar
  50. 53.
    Macris MP, Parnis SM, Frazier OH, Fuqua JM Jr., Jarvik RK. Development of an implantable ventricular assist system. Ann Thorac Surg 1997;63:367–70.PubMedCrossRefGoogle Scholar
  51. 54.
    Nishida H, Koyanagi H. Rotary blood pump: paracorporeal, implantable, percutaneous? Artif Organs 1997 Jul;21:589–91.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Tofy Mussivand
  • Paul J. Hendry
  • Roy G. Masters
  • Wilbert J. Keon

There are no affiliations available

Personalised recommendations